跳至主要内容
临床试验/NCT02959112
NCT02959112终止不适用

Epinephrine Sprayed on the Papilla and Rectal Indomethacin Versus Sterile Water Sprayed on the Papilla and Rectal Indomethacin for Preventing Pancreatitis After Endoscopic Retrograde Cholangiopancreatography: A Prospective, Randomized, Controlled Trial

Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran1 个研究点 分布在 1 个国家目标入组 548 人开始时间: 2016年5月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
终止
发起方
入组人数
548
试验地点
1
主要终点
Number of participants with pancreatitis after endoscopic retrograde cholangiopancreatography, used consensus definition

研究概览

简要总结

This multicentre randomised controlled trial included patients aged >18 years with an indication for ERCP and naive major papilla. All patients received 100 mg of rectal indomethacin and 10 ml of either sterile water or a 1:10,000 epinephrine dilution. Patients were asked about PEP symptoms via telephone 24 hours and 7 days after the procedure.

详细描述

This multicentre randomised placebo-controlled trial was conducted in two hospitals in Mexico: the National Institute of Medical Sciences and Nutrition "Salvador Zubirán" (INCMNSZ) in Mexico City, and Bernardette Hospital in Jalisco. The study was approved by both institutional review boards. All patients provided written informed consent.

All patients were given a dose of rectal indomethacin (100 mg) at the beginning of the ERCP. Depending on the experimental group, either 10 ml of sterile water or 10 ml of a 1:10,000 epinephrine dilution (0.1 mg/ml) was sprayed on the ampulla through a biliary balloon or a sphincterotome, avoiding any direct contact with the papilla during irrigation at the end of the procedure.

After the procedure, patients were monitored in the recovery room for 2 hours and then discharged. Symptoms of acute pancreatitis or any other complication were interrogated at baseline while in the recovery room, and then by telephone 24 hours and 7 days after the procedure. Serum levels of pancreatic enzymes were determined only if the patient developed abdominal pain after ERCP.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
Triple (Participant, Care Provider, Outcomes Assessor)

盲法说明

As the two solutions are colourless, the endoscopist, nurse and patient were all blinded to the intervention. Investigators who participated in the evaluation of post-ERCP complications were also blinded to group allocation.

入排标准

年龄范围
18 Years 至 99 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Age 18 years or older
  • Patient with an indication for endoscopic retrograde cholangiopancreatography
  • Patient without prior endoscopic retrograde cholangiopancreatography
  • Patient who accept contact by telephone

排除标准

  • Previous sphincterotomy
  • Allergy to epinephrine or indomethacin
  • NSAIDs use in the prior week
  • Pancreatic cancer located in the head
  • Chronic pancreatitis
  • Renal failure (Cr >1.4 mg / dl)
  • Indication for endotracheal intubation independent of endoscopic retrograde cholangiopancreatography
  • Biliodigestive derivation
  • Pregnant patients

研究组 & 干预措施

Epinephrine sprayed on the papilla and rectal indomethacin

Active Comparator

Epinephrine 1 mg/1 mL + 9 mL of sterile water are sprayed on the papilla at the end of the endoscopic retrograde cholangiopancreatography and 100 mg of indomethacin rectal suppository is administered at the beginning of the procedure

干预措施: Epinephrine (Drug)

Epinephrine sprayed on the papilla and rectal indomethacin

Active Comparator

Epinephrine 1 mg/1 mL + 9 mL of sterile water are sprayed on the papilla at the end of the endoscopic retrograde cholangiopancreatography and 100 mg of indomethacin rectal suppository is administered at the beginning of the procedure

干预措施: Sterile water (Other)

Epinephrine sprayed on the papilla and rectal indomethacin

Active Comparator

Epinephrine 1 mg/1 mL + 9 mL of sterile water are sprayed on the papilla at the end of the endoscopic retrograde cholangiopancreatography and 100 mg of indomethacin rectal suppository is administered at the beginning of the procedure

干预措施: Indomethacin Rectal Suppository (Drug)

Sterile water sprayed on the papilla and rectal indomethacin

Placebo Comparator

10 mL of sterile water are sprayed on the papilla at the end of the endoscopic retrograde cholangiopancreatography and 100 mg of indomethacin rectal suppository is administered at the beginning of the procedure

干预措施: Sterile water (Other)

Sterile water sprayed on the papilla and rectal indomethacin

Placebo Comparator

10 mL of sterile water are sprayed on the papilla at the end of the endoscopic retrograde cholangiopancreatography and 100 mg of indomethacin rectal suppository is administered at the beginning of the procedure

干预措施: Indomethacin Rectal Suppository (Drug)

结局指标

主要结局

Number of participants with pancreatitis after endoscopic retrograde cholangiopancreatography, used consensus definition

时间窗: 7 days

Consensus definition for post endoscopic retrograde cholangiopancreatography pancreatitis is: (1) new or worsened abdominal pain, (2) new or prolongation of hospitalization for at least 2 days, and (3) serum amylase or lipase 3 times or more the upper limit of normal, measured more than 24 hours after the procedure

次要结局

  • Risk factors associated with the development of pancreatitis after endoscopic retrograde cholangiopancreatography assessed by relative risk(7 days)

研究者

发起方
Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran
申办方类型
Other
责任方
Principal Investigator
主要研究者

FELIX IGNACIO TELLEZ AVILA

M.D., M.Sc., Ph. D.

Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran

研究点 (1)

Loading locations...

相似试验